Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Establish the maximum tolerated dose (MTD) of the study drug.
Part 1
Yes
United States: Food and Drug Administration
ARRAY-520-211
NCT00637052
February 2008
June 2010
Name | Location |
---|---|
University of Texas, M.D. Anderson Cancer Center | Houston, Texas 77030 |
Emory University School of Medicine, Winship Cancer Center | Atlanta, Georgia 30322 |